T1	CompanyName 73 99	ACLARIS THERAPEUTICS, INC.
T2	CompanyName 104 119	EPI HEALTH, LLC
T3	ClauseDefinition 212 215	(i)
T4	ClauseDefinition 233 237	(ii)
T5	ClauseDefinition 431 434	(i)
T6	ClauseDefinition 452 456	(ii)
T7	ClauseDefinition 633 636	(i)
T8	ClauseDefinition 654 658	(ii)
T9	ClauseDefinition 839 842	(i)
T10	ClauseDefinition 860 864	(ii)
T11	ClauseDefinition 343 344	i
T12	ClauseDefinition 544 546	ii
T13	ClauseDefinition 749 752	iii
T14	ClauseDefinition 964 966	iv
T15	ClauseDefinition 1053 1056	(i)
T16	ClauseDefinition 1074 1078	(ii)
T17	ClauseDefinition 1169 1193	ASSET PURCHASE AGREEMENT
T18	Date 1250 1266	October 10, 2019
T19	CompanyName 1318 1344	Aclaris Therapeutics, Inc.
T20	CompanyName 1348 1368	Delaware corporation
T21	CompanyName 1385 1400	EPI Health, LLC
T22	CompanyName 1404 1444	South Carolina limited liability company
T23	ClauseDefinition 1569 1577	RECITALS
T24	ClauseDefinition 2187 2199;2200 2211	ARTICLE 1    DEFINITIONS
T25	ClauseDefinition 2212 2215	1.1
T26	ClauseDefinition 2510 2513	1.2
T27	ClauseDefinition 3014 3017	1.3
T28	ClauseDefinition 3063 3066	1.4
T29	ClauseDefinition 3202 3205	1.5
T30	ClauseDefinition 3358 3361	1.6
T31	ClauseDefinition 3543 3546	1.7
T32	TermDefinition 2223 2243	Action or Proceeding
T33	TermDefinition 2521 2530	Affiliate
T34	TermDefinition 3026 3034	Allergan
T35	CompanyName 3042 3061	Allergan Sales, LLC
T36	TermDefinition 3075 3087	Allergan APA
T37	Date 3172 3188	October 15, 2018
T38	TermDefinition 3214 3226	Allergan TSA
T39	Date 3326 3343	November 30, 2018
T40	TermDefinition 3370 3386	Aspect Agreement
T41	Date 3453 3467	August 3, 2009
T42	CompanyName 3484 3509	Vicept Therapeutics, Inc.
T43	CompanyName 3514 3542	Aspect Pharmaceuticals, LLC.
T44	ClauseDefinition 3704 3707	(i)
T45	ClauseDefinition 3725 3729	(ii)
T46	TermDefinition 3828 3849	Assigned Domain Names
T47	TermDefinition 3906 3923	Assigned Know-How
T48	ClauseDefinition 3817 3820	1.8
T49	ClauseDefinition 3895 3898	1.9
T50	ClauseDefinition 4141 4145	1.10
T51	TermDefinition 4152 4168	Assigned Patents
T52	ClauseDefinition 4387 4391	1.11
T53	TermDefinition 4398 4417	Assigned Trademarks
T54	ClauseDefinition 4461 4465	1.12
T55	TermDefinition 4472 4491	Assumed Liabilities
T56	ClauseDefinition 4736 4742	1.12.1
T57	ClauseMention 5264 5275	Section 4.3
T58	ClauseDefinition 5306 5312	1.12.2
T59	ClauseDefinition 5374 5380	1.12.3
T60	TermDefinition 5593 5605	Bill of Sale
T61	ClauseDefinition 5582 5586	1.13
T62	ClauseDefinition 5842 5846	1.14
T63	TermDefinition 5852 5864	Business Day
T64	Location 5978 5995	State of New York
T65	ClauseDefinition 6099 6103	1.15
T66	TermDefinition 6110 6126	Calendar Quarter
T67	TimePeriodLimitation 6158 6173	three (3) month
T68	Date 6189 6197	March 31
T69	Date 6199 6206	June 30
T70	Date 6208 6220	September 30
T71	Date 6226 6237	December 31
T72	ClauseDefinition 6239 6243	1.16
T73	TermDefinition 6249 6262	Calendar Year
T74	Date 6292 6301	January 1
T75	TimePeriodLimitation 6313 6352	twelve (12) consecutive calendar months
T76	Date 6362 6373	December 31
T77	ClauseDefinition 6375 6379	1.17
T78	ClauseDefinition 6441 6445	1.18
T79	TermDefinition 6385 6388	CMS
T80	TermDefinition 6451 6455	Code
T81	Other 6400 6439	Center for Medicare & Medicaid Services
T82	RegulationDocuments 6467 6501	U.S. Internal Revenue Code of 1986
T83	ClauseDefinition 6603 6606	(i)
T84	ClauseDefinition 6624 6628	(ii)
T85	ClauseDefinition 6716 6720	1.19
T86	TermDefinition 6727 6746	Combination Product
T87	ClauseDefinition 7401 7405	1.20
T88	ClauseDefinition 6756 6757;6758 6760	( a)
T89	ClauseDefinition 6937 6940	(b)
T90	ClauseMention 7299 7302	(a)
T91	ClauseMention 7351 7354	(b)
T92	TermDefinition 7384 7399	Other Products.
T93	TermDefinition 7412 7443	Commercially Reasonable Efforts
T94	ClauseMention 7456 7475	Section 3.1.2(f)(i)
T95	ClauseDefinition 8308 8312	1.21
T96	TermDefinition 8318 8335	Competing Product
T97	TimePeriodLimitation 8594 8617	twenty-four (24) months
T98	ClauseDefinition 8961 8965	1.22
T99	TermDefinition 8972 8997	Confidentiality Agreement
T100	Date 9072 9088	January 24, 2019
T101	ClauseDefinition 9123 9127	1.23
T102	TermDefinition 9134 9159	Contemplated Transactions
T103	ClauseDefinition 9252 9256	1.24
T104	TermDefinition 9263 9270	Control
T105	TermDefinition 9649 9654	Cover
T106	TermDefinition 9660 9667	Covered
T107	ClauseDefinition 9639 9643	1.25
T108	ClauseDefinition 9943 9947	1.26
T109	TermDefinition 9954 9971	Covered Inventory
T110	ClauseDefinition 10104 10107	(i)
T111	ClauseDefinition 10211 10214	(i)
T112	ClauseDefinition 10232 10236	(ii)
T113	ClauseDefinition 10340 10344	(ii)
T114	ClauseDefinition 10545 10550	(iii)
T115	TermDefinition 10570 10577	Dollars
T117	ClauseDefinition 10560 10564	1.27
T118	ClauseDefinition 10608 10612	1.28
T119	TermDefinition 10619 10634	Earnout Product
T120	ClauseDefinition 10649 10652	(i)
T121	ClauseDefinition 10674 10678	(ii)
T122	ClauseDefinition 11068 11073	(iii)
T123	TermDefinition 11338 11349	Encumbrance
T124	ClauseDefinition 11328 11332	1.29
T125	ClauseDefinition 11572 11576	1.30
T126	TermDefinition 11583 11595	Escrow Agent
T127	CompanyName 11603 11617	Citibank, N.A.
T128	ClauseDefinition 11618 11622	1.31
T129	TermDefinition 11628 11644	Escrow Agreement
T130	TermDefinition 11779 11792	Escrow Amount
T131	Money 11851 11860	1,750,000
T132	ClauseDefinition 11863 11867	1.33
T133	TermDefinition 11874 11881	Exploit
T134	TermDefinition 11887 11899	Exploitation
T135	ClauseDefinition 12156 12160	1.34
T136	TermDefinition 12166 12183	Ex-U.S. Territory
T138	ClauseDefinition 12238 12242	1.35
T139	TermDefinition 12248 12263	Excluded Assets
T140	TermDefinition 12402 12405	FDA
T141	Other 12417 12459	United States Food and Drug Administration
T142	TermDefinition 12503 12508	FFDCA
T143	RegulationDocuments 12520 12576	United States Food, Drug and Cosmetic Act, 21 U.S.C. 301
T144	ClauseDefinition 12730 12734	1.38
T145	TermDefinition 12741 12768	Fundamental Representations
T146	ClauseMention 12834 12845	Section 4.1
T147	ClauseMention 12876 12887	Section 4.2
T148	ClauseMention 12904 12922	(b) of Section 4.3
T149	ClauseMention 12949 12960	Section 4.8
T150	ClauseMention 12978 12989	Section 4.9
T151	ClauseMention 13002 13016	Section 4.10.5
T152	ClauseDefinition 13143 13146	(i)
T153	ClauseDefinition 13164 13168	(ii)
T154	ClauseDefinition 13256 13260	1.39
T155	TermDefinition 13267 13271	GAAP
T157	ClauseDefinition 13326 13330	1.40
T158	TermDefinition 13337 13359	Governmental Authority
T159	ClauseDefinition 13486 13489	(a)
T160	ClauseDefinition 13521 13524	(b)
T161	ClauseDefinition 13623 13626	(c)
T162	ClauseDefinition 13651 13655	1.41
T163	TermDefinition 13661 13666	HIPAA
T164	RegulationDocuments 13678 13737	Health Insurance Portability and Accountability Act of 1996
T165	ClauseDefinition 13739 13743	1.42
T166	TermDefinition 13749 13752	IND
T167	RegulationDocuments 13831 13833;13834 13847	21 C.F.R. §  321
T168	ClauseDefinition 13957 13961	1.43
T169	TermDefinition 13967 13988	Intellectual Property
T170	ClauseDefinition 14063 14066	(a)
T171	ClauseDefinition 14117 14120	(b)
T172	ClauseDefinition 14187 14190	(c)
T173	ClauseDefinition 14200 14203	(d)
T174	ClauseDefinition 14324 14327	(e)
T175	ClauseDefinition 14660 14664	1.44
T176	TermDefinition 14670 14698	Intellectual Property Rights
T177	ClauseDefinition 14795 14799	1.45
T178	TermDefinition 14805 14814	Inventory
T179	ClauseDefinition 15200 15203	(i)
T180	ClauseDefinition 15266 15270	(ii)
T181	ClauseDefinition 15352 15357	(iii)
T182	ClauseDefinition 15405 15409	1.46
T183	TermDefinition 15416 15424	Know-How
T184	ClauseDefinition 15822 15826	1.47
T185	TermDefinition 15832 15841	Knowledge
T186	ClauseDefinition 15917 15921	1.48
T187	TermDefinition 15927 15930	Law
T188	TermDefinition 15936 15940	Laws
T189	ClauseDefinition 16388 16391	(i)
T190	ClauseDefinition 16409 16413	(ii)
T191	ClauseDefinition 16603 16607	1.49
T192	TermDefinition 16613 16622	Liability
T193	TermDefinition 16628 16639	Liabilities
T194	ClauseDefinition 17361 17365	1.50
T195	TermDefinition 17372 17376	Loss
T196	TermDefinition 17382 17388	Losses
T197	ClauseDefinition 17760 17764	1.51
T198	ClauseDefinition 17793 17797	1.52
T199	TermDefinition 17804 17827	Material Adverse Effect
T200	ClauseDefinition 18448 18451	(a)
T202	ClauseDefinition 18563 18566	(b)
T203	ClauseDefinition 18817 18820	(c)
T204	ClauseDefinition 18928 18931	(d)
T205	ClauseDefinition 19072 19075	(e)
T206	ClauseDefinition 19215 19218	(f)
T207	ClauseDefinition 19324 19327	(g)
T208	ClauseDefinition 19774 19777	(h)
T209	ClauseMention 19921 19924	(a)
T210	ClauseMention 19926 19929	(b)
T211	ClauseMention 19933 19936	(f)
T212	ClauseDefinition 20207 20210	(i)
T213	ClauseDefinition 20228 20232	(ii)
T214	TermDefinition 20519 20522	NDA
T215	ClauseDefinition 20509 20513	1.53
T216	RegulationDocuments 20603 20614	21 CFR §314
T217	ClauseDefinition 20693 20697	1.54
T218	TermDefinition 20704 20707	NDC
T219	ClauseDefinition 20758 20762	1.55
T220	TermDefinition 20769 20778	Net Sales
T221	ClauseDefinition 21344 21347	(a)
T222	ClauseDefinition 21471 21474	(b)
T223	ClauseDefinition 21656 21659	(c)
T224	ClauseDefinition 21916 21919	(d)
T225	ClauseDefinition 22105 22108	(e)
T226	ClauseDefinition 22240 22243	(f)
T227	ClauseDefinition 22499 22502	(g)
T228	ClauseDefinition 22861 22864	(i)
T229	ClauseDefinition 22882 22886	(ii)
T230	ClauseDefinition 22974 22977	(h)
T231	RegulationDocuments 23066 23114;23115 23117;23118 23129	Patient Protection and Affordable Care Act, Pub. L. No. 111-148
T232	ClauseDefinition 24586 24588	i.
T233	TimePeriodLimitation 25109 25135	twelve (12) calendar month
T234	ClauseDefinition 25153 25156	ii.
T235	ClauseDefinition 25633 25637	iii.
T236	ClauseDefinition 26196 26199	(i)
T237	ClauseDefinition 26217 26221	(ii)
T238	ClauseDefinition 26582 26586	1.56
T239	TermDefinition 26592 26597	Order
T240	ClauseDefinition 26930 26934	1.57
T241	TermDefinition 26941 26959	Patent Assignments
T243	ClauseDefinition 27330 27334	1.58
T244	TermDefinition 27340 27346	Patent
T245	TermDefinition 27352 27359	Patents
T246	ClauseDefinition 27367 27370	(a)
T247	ClauseDefinition 27510 27513	(b)
T248	ClauseDefinition 27763 27766	(c)
T249	ClauseMention 27826 27829	(a)
T250	ClauseMention 27833 27836	(b)
T251	ClauseDefinition 27838 27842	1.59
T252	TermDefinition 27849 27870	Permitted Encumbrance
T253	ClauseDefinition 27878 27881	(a)
T254	ClauseDefinition 28004 28007	(b)
T255	ClauseDefinition 28147 28150	(c)
T256	ClauseDefinition 28368 28371	(d)
T257	ClauseDefinition 28482 28485	(e)
T258	Date 28547 28559	May 16, 2014
T259	CompanyName 28576 28596	Galderma Pharma S.A.
T260	CompanyName 28598 28624	Galderma Laboratories Inc.
T261	CompanyName 28626 28653	Allergan and Allergan, Inc.
T262	ClauseDefinition 28659 28662	(f)
T263	ClauseDefinition 28936 28940	1.60
T264	TermDefinition 28946 28952	Person
T265	TermDefinition 29123 29145	Pre-Closing Tax Period
T266	ClauseDefinition 29113 29117	1.61
T267	Date 29191 29208	November 30, 2018
T268	ClauseDefinition 29353 29357	1.62
T269	TermDefinition 29364 29389	Product Books and Records
T270	ClauseDefinition 29730 29733	(i)
T271	ClauseDefinition 29751 29755	(ii)
T272	ClauseDefinition 31489 31493	1.63
T273	TermDefinition 31499 31506	Rebates
T274	ClauseMention 31593 31607	Section 7.15.1
T275	ClauseDefinition 32079 32083	1.64
T276	ClauseDefinition 32111 32115	1.65
T277	TermDefinition 32121 32141	Retained Liabilities
T278	ClauseDefinition 32359 32362	(i)
T279	ClauseDefinition 32532 32536	(ii)
T280	ClauseMention 33009 33020	Section 4.3
T281	ClauseDefinition 33050 33054	1.66
T282	TermDefinition 33061 33075	Retained Taxes
T283	ClauseDefinition 33083 33084;33085 33087	( i)
T284	ClauseMention 33418 33431	Section 7.8.3
T285	ClauseDefinition 33433 33437	(ii)
T286	ClauseDefinition 33631 33634	(i)
T287	ClauseDefinition 33652 33656	(ii)
T288	ClauseDefinition 33775 33780	(iii)
T289	ClauseDefinition 33871 33875	1.67
T290	TermDefinition 33881 33897	RHOFADE Business
T291	ClauseDefinition 34161 34164	(a)
T292	ClauseMention 34233 34242	ARTICLE 4
T294	ClauseDefinition 34348 34351	(b)
T295	ClauseDefinition 34456 34460	1.68
T296	TermDefinition 34466 34477	RHOFADE IND
T297	ClauseDefinition 34762 34766	1.69
T298	TermDefinition 34773 34797	RHOFADE Licensed Patents
T299	Date 34912 34929	November 30, 2018
T300	CompanyName 34946 34960	Allergan, Inc.
T301	CompanyName 34964 34984	Delaware corporation
T302	ClauseDefinition 34998 35002	1.70
T303	TermDefinition 35008 35019	RHOFADE NDA
T304	Date 35085 35101	January 18, 2017
T305	ClauseDefinition 35212 35216	1.71
T306	TermDefinition 35222 35237	RHOFADE Product
T307	ClauseDefinition 35392 35396	1.72
T308	TermDefinition 35402 35419	Seller NDC Number
T309	ClauseDefinition 35468 35472	1.73
T310	TermDefinition 35478 35502	Seller’s Names and Marks
T311	ClauseMention 35530 35543	Schedule 1.73
T312	ClauseDefinition 35545 35549	1.74
T313	TermDefinition 35556 35571	Straddle Period
T314	Date 35620 35637	November 30, 2018
T315	ClauseDefinition 35673 35677	1.75
T316	TermDefinition 35683 35686	Tax
T317	TermDefinition 35692 35697	Taxes
T319	ClauseDefinition 36829 36832	(i)
T320	ClauseDefinition 36850 36854	(ii)
T321	ClauseDefinition 36942 36946	1.76
T322	TermDefinition 36952 36962	Tax Return
T324	TermDefinition 37321 37330	Territory
T325	ClauseDefinition 37311 37315	1.77
T326	ClauseDefinition 37356 37360	1.78
T327	TermDefinition 37367 37378	Third Party
T328	ClauseDefinition 37456 37460	1.79
T329	TermDefinition 37467 37476	Trademark
T330	ClauseDefinition 37847 37851	1.80
T331	TermDefinition 37858 37879	Trademark Assignments
T333	ClauseDefinition 38256 38260	1.81
T334	TermDefinition 38267 38288	Transaction Documents
T335	ClauseDefinition 38495 38499	1.82
T336	TermDefinition 38505 38519	Transfer Taxes
T337	ClauseDefinition 38849 38853	1.83
T338	TermDefinition 38859 38877	Transferred Assets
T339	ClauseDefinition 39029 39033	1.84
T340	TermDefinition 39040 39065	Transferred Registrations
T341	TermDefinition 39588 39601	United States
T342	ClauseDefinition 39578 39582	1.85
T343	TermDefinition 39607 39611	U.S.
T344	Location 39623 39647	United States of America
T116	ClauseDefinition 39692 39696	1.86
T137	TermDefinition 39703 39714	Valid Claim
T156	ClauseDefinition 39722 39725	(i)
T201	ClauseDefinition 40054 40057	(i)
T242	ClauseDefinition 40075 40079	(ii)
T293	ClauseDefinition 40469 40473	(ii)
T318	TimePeriodLimitation 40621 40636	seven (7) years
T323	ClauseDefinition 40864 40868	1.87
T332	TermDefinition 40875 40891	Vicept Agreement
T345	Date 40954 40967	July 18, 2011
T346	CompanyName 40982 40996	Allergan, Inc.
T347	CompanyName 40998 41024	Erythema Acquisition, Inc.
T348	CompanyName 41026 41051	Vicept Therapeutics, Inc.
T349	Date 41209 41227	September 21, 2018
T350	CompanyPerson 41056 41066	Albert Cha
T351	CompanyPersonPosition 41070 41109	Shareholders’ Representative thereunder
T352	ClauseDefinition 41264 41296	1.88     Additional Definitions.
T353	ClauseDefinition 41488 41491	(i)
T354	ClauseDefinition 41509 41513	(ii)
T355	ClauseDefinition 41693 41696	(i)
T356	ClauseDefinition 41714 41718	(ii)
T358	ClauseDefinition 41848 41886	2.1       Purchase and Sale of Assets.
T359	ClauseDefinition 42332 42358	2.2       Excluded Assets.
T360	ClauseDefinition 42621 42650	2.3       No Implied License.
T361	ClauseDefinition 42887 42923	2.4       Assumption of Liabilities.
T362	ClauseDefinition 43150 43181	2.5       Retained Liabilities.
T363	ClauseDefinition 43390 43427	2.6       Assignability and Consents.
T364	ClauseDefinition 43612 43615	(a)
T365	ClauseDefinition 43640 43643	(b)
T366	ClauseMention 43748 43751	(a)
T367	ClauseMention 43756 43759	(b)
T368	ClauseMention 43778 43789	Section 4.3
T369	ClauseMention 44302 44313	Section 2.6
T370	ClauseDefinition 45067 45070	(i)
T371	ClauseMention 45151 45162	Section 2.6
T372	ClauseDefinition 45405 45408	(i)
T373	ClauseDefinition 45426 45430	(ii)
T374	ClauseDefinition 45575 45579	(ii)
T375	ClauseDefinition 46546 46569	2.7       Risk of Loss.
T357	ClauseDefinition 41806 41819;41820 41847	ARTICLE 2     PURCHASE AND SALE OF ASSETS
T376	ClauseDefinition 46793 46831	ARTICLE 3   PURCHASE PRICE AND PAYMENT
T377	ClauseDefinition 46832 46856	3.1       Consideration.
T378	ClauseDefinition 47158 47205	3.1.1    Upfront Payment and Inventory Payment.
T379	ClauseDefinition 47255 47258	(a)
T380	Money 47289 47302	35,000,000.00
T381	ClauseDefinition 47438 47441	(b)
T382	ClauseMention 47497 47508	Section 3.3
T383	ClauseDefinition 47543 47546	(c)
T384	ClauseDefinition 47767 47776;47777 47803	3.1.2     Sales Milestones; Royalty.
T385	ClauseMention 47838 47854	Section 3.1.2(a)
T386	ClauseMention 47913 47929	Section 3.1.2(a)
T387	ClauseDefinition 47960 47963	(a)
T388	ClauseDefinition 48006 48009	(i)
T389	ClauseDefinition 48246 48250	(ii)
T390	ClauseDefinition 48574 48577	(i)
T391	ClauseDefinition 48595 48599	(ii)
T392	ClauseDefinition 48687 48692	(iii)
T393	TimePeriodLimitation 49014 49027	Calendar Year
T394	ClauseDefinition 49190 49193	(b)
T395	ClauseDefinition 49359 49362	(c)
T396	ClauseDefinition 49905 49908	(i)
T397	ClauseDefinition 50045 50049	(ii)
T398	TimePeriodLimitation 50050 50064	ten (10) years
T399	ClauseDefinition 50183 50186	(d)
T400	ClauseDefinition 50372 50375	(e)
T401	ClauseDefinition 50499 50502	(a)
T402	ClauseDefinition 50553 50556	(b)
T403	ClauseDefinition 50650 50653	(c)
T404	ClauseDefinition 50715 50718	(f)
T405	ClauseDefinition 50737 50740	(i)
T406	ClauseDefinition 51156 51160	(ii)
T407	ClauseMention 51186 51197	Section 3.2
T408	ClauseMention 51226 51241	Section 2.07(f)
T409	CompanyName 51561 51586	Vicept Therapeutics, Inc.
T410	CompanyName 51590 51617	Aspect Pharmaceuticals, LLC
T411	ClauseMention 51798 51802	(ii)
T412	ClauseDefinition 51977 51980	(i)
T413	ClauseDefinition 51998 52002	(ii)
T414	ClauseMention 52124 52144	Section 3.1.2(f)(ii)
T415	ClauseMention 52212 52232	Section 3.1.2(f)(ii)
T416	ClauseMention 52433 52453	Section 3.1.2(f)(ii)
T417	CompanyName 52518 52543	Vicept Therapeutics, Inc.
T418	CompanyName 52548 52570;52571 52576	Aspect Pharmaceuticals , LLC
T419	ClauseMention 52624 52644	Section 3.1.2(f)(ii)
T420	ClauseDefinition 52646 52649	(g)
T421	ClauseDefinition 53897 53900	(i)
T422	ClauseDefinition 53957 53961	(ii)
T423	ClauseDefinition 54028 54033	(iii)
T424	ClauseDefinition 54093 54097	(iv)
T425	TimePeriodLimitation 48068 48081	Calendar Year
T426	TimePeriodLimitation 48307 48320	Calendar Year
T427	TimePeriodLimitation 48748 48761	Calendar Year
T428	TimePeriodLimitation 54134 54147	Calendar Year
T429	TimePeriodLimitation 54310 54323	Calendar Year
T430	ClauseMention 54760 54776	Section 3.1.2(g)
T431	ClauseDefinition 55951 55993	3.1.3    Additional Ex-U.S. Consideration.
T432	ClauseMention 56045 56061	Section 3.1.2(c)
T433	ClauseDefinition 56418 56421	(i)
T434	ClauseDefinition 56439 56443	(ii)
T435	ClauseMention 56819 56822	(i)
T436	ClauseMention 57060 57064	(ii)
T437	ClauseDefinition 57804 57809	3.1.4
T438	ClauseMention 57947 57960	Section 3.4.2
T439	ClauseDefinition 58080 58117	3.2       Delivery of Purchase Price.
T440	ClauseDefinition 58450 58453	(a)
T441	ClauseDefinition 58665 58668	(b)
T442	ClauseDefinition 59095 59150	3.3       Inventory Payment; Purchase Price Adjustment.
T443	ClauseDefinition 59151 59156	3.3.1
T444	ClauseDefinition 59861 59866	3.3.2
T445	ClauseDefinition 60229 60232	(i)
T446	ClauseDefinition 60250 60254	(ii)
T447	ClauseDefinition 60841 60846	3.3.3
T448	ClauseDefinition 61808 61811	(x)
T449	ClauseDefinition 61947 61950	(y)
T450	ClauseMention 63443 63456	Section 3.3.3
T451	ClauseDefinition 63641 63646	3.3.4
T452	TermDefinition 63657 63696	Closing Date Inventory Value Adjustment
T453	ClauseMention 63917 63930	Section 3.3.3
T454	ClauseDefinition 63932 63935	(a)
T455	ClauseDefinition 64319 64322	(i)
T456	ClauseDefinition 64340 64344	(ii)
T457	ClauseDefinition 64432 64435	(b)
T458	ClauseDefinition 64751 64756	3.3.5
T459	ClauseDefinition 64769 64823	3.4       Tax Treatment; Allocation of Purchase Price.
T460	ClauseDefinition 64824 64829	3.4.1
T461	RegulationDocuments 65176 65203	Section 1313(a) of the Code
T462	ClauseDefinition 65205 65210	3.4.2
T463	RegulationDocuments 65550 65574	Section 1060 of the Code
T464	RegulationDocuments 65657 65690	Sections 1060 and 338 of the Code
T465	RegulationDocuments 65879 65915	Treasury Regulations Section 1.338-6
T466	RegulationDocuments 66110 66156	Treasury Regulations Section 1.338-6 Class VII
T467	RegulationDocuments 67039 67053	IRS Forms 8594
T468	ClauseDefinition 67205 67217;67218 67258	ARTICLE 4    REPRESENTATIONS AND WARRANTIES OF SELLER
T469	ClauseMention 67489 67498	ARTICLE 4
T470	ClauseMention 67666 67675	ARTICLE 4
T471	ClauseDefinition 67849 67852	(i)
T472	ClauseDefinition 67870 67874	(ii)
T473	ClauseDefinition 67962 67999	4.1       Organization and Authority.
T474	Location 68086 68103	State of Delaware
T475	ClauseDefinition 69697 69713	4.2       Title.
T476	ClauseDefinition 69974 70007	4.3       No Conflicts; Consents.
T477	ClauseDefinition 70407 70410	(a)
T478	ClauseDefinition 70531 70534	(b)
T479	ClauseDefinition 70683 70686	(c)
T480	ClauseDefinition 71144 71147	(d)
T481	RegulationDocuments 71271 71286	21 CFR § 314.72
T482	RegulationDocuments 71323 71335	21 CFR § 312
T483	ClauseMention 71533 71544	Section 4.3
T484	ClauseMention 71601 71604	(a)
T485	ClauseMention 71606 71609	(c)
T486	ClauseMention 71614 71617	(d)
T487	ClauseDefinition 71891 71927	4.4       Litigation; No Violations.
T488	ClauseMention 71953 71964	Section 4.4
T489	ClauseDefinition 72166 72169	(i)
T490	ClauseDefinition 72187 72191	(ii)
T491	ClauseDefinition 73065 73097	4.5       Intellectual Property.
T492	ClauseDefinition 73098 73103	4.5.1
T493	ClauseMention 73108 73121	Section 4.5.1
T494	ClauseDefinition 73655 73658	(a)
T495	ClauseDefinition 73725 73728	(b)
T496	ClauseDefinition 73756 73759	(c)
T497	ClauseDefinition 73823 73826	(d)
T498	ClauseDefinition 74025 74030	4.5.2
T499	ClauseMention 74498 74511	Section 4.5.1
T500	ClauseDefinition 74969 74974	4.5.3
T501	ClauseMention 75001 75014	Section 4.5.3
T502	ClauseDefinition 75114 75117	(a)
T503	Date 75124 75141	November 30, 2018
T504	ClauseDefinition 75143 75146	(i)
T505	ClauseDefinition 75467 75471	(ii)
T506	ClauseDefinition 75535 75538	(b)
T507	ClauseDefinition 75658 75663	4.5.4
T508	ClauseDefinition 76030 76033	(i)
T509	ClauseDefinition 76051 76055	(ii)
T510	ClauseDefinition 76640 76645	4.5.5
T511	ClauseMention 76672 76685	Section 4.5.5
T512	ClauseDefinition 77244 77249	4.5.6
T513	ClauseMention 77277 77290	Section 4.5.6
T514	ClauseDefinition 77730 77735	4.5.7
T515	Date 77864 77881	November 30, 2018
T516	Date 78105 78122	November 30, 2018
T517	ClauseMention 78147 78160	Section 4.5.7
T518	ClauseDefinition 78306 78311	4.5.8
T519	Date 78388 78405	November 30, 2018
T520	ClauseDefinition 78717 78722	4.5.9
T521	Date 78799 78816	November 30, 2018
T522	Date 79235 79252	November 30, 2018
T523	ClauseDefinition 79254 79274	4.6       Contracts.
T524	ClauseDefinition 79619 79622	(i)
T525	ClauseDefinition 79640 79644	(ii)
T526	ClauseMention 80228 80239	Section 4.6
T527	Date 80445 80462	November 30, 2018
T528	ClauseMention 80917 80928	Section 4.6
T529	ClauseDefinition 81404 81433	4.7       Regulatory Matters.
T530	ClauseDefinition 81434 81439	4.7.1
T531	Date 81449 81466	November 30, 2018
T532	ClauseMention 81744 81757	Section 4.7.1
T533	ClauseMention 82070 82083	Section 4.7.1
T534	ClauseDefinition 83254 83257	(a)
T535	RegulationDocuments 83273 83285	FDA Form 483
T536	ClauseDefinition 83381 83384	(b)
T537	ClauseDefinition 83488 83491	(i)
T538	ClauseDefinition 83639 83643	(ii)
T539	ClauseDefinition 83915 83918	(i)
T540	ClauseDefinition 83936 83940	(ii)
T541	ClauseDefinition 84053 84058	(iii)
T542	ClauseDefinition 84166 84171	4.7.2
T543	RegulationDocuments 84884 84918;84919 84926;84927 84940	FDA’s Compliance Policy Guide Sec. 120.100 (CPG 7150.09)
T544	ClauseDefinition 85012 85017	4.7.3
T545	ClauseDefinition 85122 85125	(a)
T546	ClauseDefinition 85269 85272	(b)
T547	Other 85335 85379	U.S. Department of Health and Human Services
T548	Date 85815 85832	November 30, 2018
T549	Date 86750 86767	November 30, 2018
T550	ClauseDefinition 86206 86211	4.7.4
T551	Date 86222 86239	November 30, 2018
T552	ClauseDefinition 86867 86870	(a)
T553	ClauseDefinition 86906 86909	(b)
T554	ClauseDefinition 86976 86979	(c)
T555	ClauseDefinition 87119 87122	(d)
T556	ClauseDefinition 87560 87565	4.7.5
T557	ClauseDefinition 87819 87822	(i)
T558	ClauseDefinition 87840 87844	(ii)
T559	ClauseDefinition 88582 88585	(x)
T560	RegulationDocuments 88602 88624	21 U.S.C. Section 335a
T561	ClauseDefinition 88647 88650	(y)
T562	RegulationDocuments 88667 88692	42 U.S.C. Section 1320a-7
T563	ClauseDefinition 88823 88847	4.8       Broker’s Fees.
T564	ClauseMention 88873 88884	Section 4.8
T565	ClauseMention 89466 89477	Section 4.8
T566	ClauseDefinition 89605 89621	4.9       Taxes.
T567	ClauseMention 89647 89658	Section 4.9
T568	ClauseDefinition 89688 89693	4.9.1
T569	ClauseDefinition 89847 89852	4.9.2
T570	RegulationDocuments 90056 90109	Code sections 1441 through 1464 and 6041 through 6049
T571	ClauseDefinition 90211 90214	(A)
T572	ClauseDefinition 90319 90322	(B)
T573	ClauseDefinition 90412 90417	4.9.3
T574	ClauseDefinition 90535 90538	(a)
T575	ClauseDefinition 90651 90654	(b)
T576	ClauseDefinition 90688 90693	4.9.4
T577	ClauseDefinition 90888 90893	4.9.5
T578	ClauseDefinition 91170 91173	(i)
T579	ClauseDefinition 91191 91195	(ii)
T580	ClauseDefinition 91283 91288	4.9.6
T581	ClauseDefinition 91443 91448	4.9.7
T582	ClauseDefinition 91682 91687	4.9.8
T583	ClauseDefinition 91758 91763	4.9.9
T584	RegulationDocuments 91885 91909	Section 1445 of the Code
T585	ClauseDefinition 91911 91955	4.10     Completeness of Transferred Assets.
T586	ClauseDefinition 91956 91962	4.10.1
T587	Date 92158 92175	November 30, 2018
T588	ClauseDefinition 92245 92251	4.10.2
T589	ClauseDefinition 92565 92571	4.10.3
T590	Date 92695 92712	November 30, 2018
T591	ClauseDefinition 92794 92800	4.10.4
T592	ClauseMention 92826 92840	Section 4.10.4
T593	ClauseDefinition 93093 93099	4.10.5
T594	ClauseDefinition 93243 93290	4.11     Compliance with Laws; Anti-Corruption.
T595	ClauseDefinition 93291 93297	4.11.1
T596	Date 93347 93364	November 30, 2018
T597	RegulationDocuments 93461 93503	U.S. Foreign Corrupt Practices Act of 1977
T598	RegulationDocuments 93517 93534	15 U.S.C. §78dd-a
T599	RegulationDocuments 93550 93579	U.S. Domestic Bribery Statute
T600	RegulationDocuments 93581 93595	18 U.S.C. §201
T601	RegulationDocuments 93602 93617	U.S. Travel Act
T602	RegulationDocuments 93619 93634	18 U.S.C. §1952
T603	RegulationDocuments 93731 93756	federal Anti-Kickback Law
T604	RegulationDocuments 93758 93777	42 U.S.C. §1320a-7b
T605	RegulationDocuments 93825 93849	federal False Claims Act
T606	RegulationDocuments 93851 93853;93854 93866	31 U.S.C. §3279
T607	RegulationDocuments 93882 93918	federal Civil Monetary Penalties Law
T608	RegulationDocuments 93920 93939	42 U.S.C. §1320a-7a
T609	RegulationDocuments 93946 93976	Physician Payment Sunshine Act
T610	RegulationDocuments 93978 93980;93981 93997	42 U.S.C. §1320a-7h
T611	RegulationDocuments 94075 94101	Accountability Act of 1996
T612	ClauseDefinition 94217 94220	(i)
T613	ClauseDefinition 94238 94242	(ii)
T614	RegulationDocuments 94374 94393	Clinical Health Act
T615	ClauseDefinition 94956 94962	4.11.2
T616	Date 95255 95272	November 30, 2018
T617	ClauseDefinition 95516 95519	(i)
T618	ClauseDefinition 95719 95723	(ii)
T619	ClauseDefinition 95879 95898	4.12     Inventory.
T620	ClauseDefinition 95899 95905	4.12.1
T621	ClauseMention 95907 95921	Section 4.12.1
T622	Date 96261 96279	September 30, 2019
T623	ClauseDefinition 97111 97117	4.12.2
T624	Date 97202 97219	November 30, 2018
T625	Date 97559 97576	November 30, 2018
T626	ClauseDefinition 98049 98052	(i)
T627	ClauseDefinition 98070 98074	(ii)
T628	Date 98199 98216	November 30, 2018
T629	ClauseDefinition 98217 98220	(i)
T630	ClauseDefinition 98339 98343	(ii)
T631	ClauseDefinition 98412 98459	4.13     Accounts Receivable; Accounts Payable.
T632	Date 98468 98485	November 30, 2018
T633	Date 98710 98727	November 30, 2018
T634	ClauseDefinition 98886 98914	4.14     Absence of Changes.
T635	Date 98922 98939	November 30, 2018
T636	Date 99149 99166	November 30, 2018
T637	Date 99276 99293	November 30, 2018
T638	Date 99384 99401	November 30, 2018
T639	ClauseDefinition 99634 99659	4.15     AMP and BP Data.
T640	ClauseMention 99687 99699	Section 4.15
T641	RegulationDocuments 99931 99950	42 U.S.C. § 1396r-8
T642	RegulationDocuments 99955 99974	42 C.F.R. § 447.500
T643	ClauseDefinition 100023 100026	(a)
T644	ClauseDefinition 100117 100120	(b)
T645	ClauseDefinition 100210 100213	(c)
T646	ClauseDefinition 100277 100280	(d)
T647	ClauseDefinition 100381 100384	(e)
T648	ClauseDefinition 100435 100439	4.16
T649	ClauseDefinition 100453 100501	4.17     No Other Representations or Warranties.
T650	ClauseMention 100568 100577	Article 4
T651	ClauseDefinition 100872 100924	ARTICLE 5    REPRESENTATIONS AND WARRANTIES OF BUYER
T652	ClauseDefinition 101007 101044	5.1       Organization and Authority.
T653	ClauseDefinition 101473 101476	(i)
T654	ClauseDefinition 101494 101498	(ii)
T655	ClauseDefinition 102441 102462	5.2       Litigation.
T656	ClauseDefinition 103042 103065	5.3       No Conflicts.
T657	ClauseDefinition 103335 103338	(a)
T658	ClauseDefinition 103461 103464	(b)
T659	ClauseDefinition 103612 103615	(c)
T660	ClauseMention 104025 104028	(a)
T661	ClauseDefinition 104539 104542	(i)
T662	RegulationDocuments 104599 104615	21 CFR §  314.72
T663	RegulationDocuments 104652 104658;104659 104665	21 CFR §  312
T664	ClauseDefinition 104830 104834	(ii)
T665	ClauseDefinition 105172 105202	5.4       Brokers and Finders.
T666	ClauseDefinition 105564 105567	(i)
T667	ClauseDefinition 105585 105589	(ii)
T668	ClauseDefinition 105677 105698	5.5       Disclaimer.
T669	ClauseMention 106297 106306	ARTICLE 4
T670	ClauseMention 106684 106693	ARTICLE 4
T671	ClauseDefinition 107265 107314	5.6       No Other Representations or Warranties.
T672	ClauseMention 107381 107390	Article 5
T673	ClauseDefinition 107688 107700;107701 107708	ARTICLE 6    CLOSING
T674	ClauseDefinition 107709 107727	6.1       Closing.
T675	Other 108004 108014	12:01 a.m.
T676	Location 108015 108023	New York
T677	ClauseDefinition 108050 108079	6.2       Closing Deliveries.
T678	ClauseDefinition 108098 108103	6.2.1
T679	ClauseDefinition 108170 108173	(a)
T680	ClauseMention 108242 108253	Section 3.2
T681	ClauseDefinition 108255 108258	(b)
T682	ClauseDefinition 108306 108309	(c)
T683	ClauseDefinition 108449 108452	(d)
T684	ClauseDefinition 108471 108474	(i)
T685	ClauseDefinition 108522 108526	(ii)
T686	ClauseDefinition 108563 108568	(iii)
T687	ClauseDefinition 108723 108726	(i)
T688	ClauseDefinition 108744 108748	(ii)
T689	ClauseDefinition 108836 108841	6.2.2
T690	ClauseDefinition 108918 108921	(a)
T691	ClauseDefinition 109048 109051	(b)
T692	ClauseDefinition 109100 109103	(c)
T693	ClauseMention 109151 109168	Schedule 6.2.2(b)
T694	ClauseDefinition 109170 109173	(d)
T695	ClauseDefinition 109316 109319	(e)
T696	ClauseDefinition 109470 109473	(f)
T697	RegulationDocuments 109484 109517	Internal Revenue Service Form W-9
T698	ClauseDefinition 109576 109579	(g)
T699	ClauseDefinition 109639 109642	(i)
T700	RegulationDocuments 109649 109666	21 C.F.R. §314.72
T701	ClauseDefinition 109709 109713	(ii)
T702	RegulationDocuments 109720 109731	21 CFR §312
T703	ClauseMention 109803 109806	(i)
T704	ClauseMention 109811 109815	(ii)
T705	ClauseDefinition 109862 109865	(h)
T706	ClauseDefinition 109991 110039	ARTICLE 7    COVENANTS AND ADDITIONAL AGREEMENTS
T707	ClauseDefinition 110040 110076	7.1       Cooperation After Closing.
T708	ClauseDefinition 110356 110380	7.2       Wrong Pockets.
T709	ClauseDefinition 110381 110387	7.2.1 
T710	ClauseDefinition 111142 111147	7.2.2
T711	ClauseDefinition 111520 111523	(i)
T712	ClauseDefinition 111541 111545	(ii)
T713	ClauseDefinition 111952 111962;111963 111982	7.3        Further Assurances.
T714	ClauseDefinition 111983 111988	7.3.1
T715	ClauseDefinition 112380 112385	7.3.2
T716	ClauseDefinition 113228 113279	7.4       Notification to Governmental Authorities.
T717	ClauseDefinition 114073 114093	7.5       Customers.
T718	ClauseDefinition 114721 114724	(a)
T719	ClauseDefinition 114934 114937	(b)
T720	ClauseDefinition 115106 115109	(i)
T721	ClauseDefinition 115127 115131	(ii)
T722	ClauseDefinition 115219 115254	7.6       Confidential Information.
T723	ClauseDefinition 115255 115260	7.6.1
T724	ClauseMention 115677 115690	Section 7.6.2
T725	ClauseDefinition 115698 115703	7.6.2
T726	ClauseMention 116493 116506	Section 7.6.2
